BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1195475)

  • 1. Prognostic value of host immunocompetence in urologic cancer patients.
    Catalona WJ; Smolev JK; Harty JI
    J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
    Catalona WJ; Chretien PB; Trahan EE
    J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
    Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
    Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin testing in genitourinary carcinoma: 2-year followup.
    Decenzo JM; Allison R; Leadbetter GW
    J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between tumour stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate.
    Adolphs HD; Steffens L
    Eur Urol; 1977; 3(1):23-5. PubMed ID: 837950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological responsiveness in patients with bladder cancer.
    Fahey JL; Brosman S; Dorey F
    Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo skin test in carcinoma bladder.
    Gupta NP; Rajagopal V; Malaviya AN; Singh SM
    Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):163-5. PubMed ID: 6545227
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological evaluation in patients with urological cancers.
    Martinez-PiƱeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Gerfo PL; Feminella J; Lattimer JK
    J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors.
    Mostofi FK; Sesterhenn I
    Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen in patients with tumors of the urogenital tract.
    Reynoso G; Chu TM; Guinan P; Murphy GP
    Cancer; 1972 Jul; 30(1):1-4. PubMed ID: 5064805
    [No Abstract]   [Full Text] [Related]  

  • 17. The occurrence of SV40-Neutralizing antibodies in sera of patients with genitourinary carcinoma.
    Shah KV; Palma LD; Murphy GP
    J Surg Oncol; 1971; 3(4):443-50. PubMed ID: 4329010
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of the DNCB test in bladder cancer. Pretreatment evaluation of immune function and 5-year follow-up of patients with urinary bladder cancer.
    Flamm J; Sagaster P; Micksche M
    Urol Int; 1984; 39(5):257-63. PubMed ID: 6506358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
    Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
    Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.